Manlong Qi

692 citations
15 papers · 514 indexed · h-index 9
Topics
Cancer-related molecular mechanisms research (4 papers)MicroRNA in disease regulation (3 papers)Genomic variations and chromosomal abnormalities (3 papers)
Partner nations
ChinaUnited States

In The Last Decade

Manlong Qi

14 papers receiving 509 citations

Peers

Manlong Qi
Comparison fields: 5 of 60
  • Molecular Biology 379
  • Cancer Research 321
  • Epidemiology 76
  • Oncology 69
  • Immunology 69
Replace Yueh‐Te Lin with:
Yueh‐Te Lin Taiwan
Ömer An Singapore
Ana Clara P. Azevedo‐Pouly United States
Conroy O. Field United States
Siwen Dang China
Mingtai Chen China
Nerea Matamala Spain
Ruifang Mi China
Donghu Yu China
Li‐Hua Yang China
Manlong Qi relative to Yueh‐Te Lin Taiwan Yueh‐Te Lin's profile →
Citations per field
00.5×10×12.5×
Yueh‐Te Lin · 1×
Citations per year

Countries citing papers authored by Manlong Qi

Since Specialization
Citations

This map shows the geographic impact of Manlong Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manlong Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manlong Qi more than expected).

Fields of papers citing papers by Manlong Qi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manlong Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manlong Qi. The network helps show where Manlong Qi may publish in the future.

Co-authorship network of co-authors of Manlong Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Manlong Qi. A scholar is included among the top collaborators of Manlong Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manlong Qi. Manlong Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 0
2 50
3 97
4 41
5 58
6 8
7 26
8 41
9 31
10 5
11 17
12 133
13 1
14 4
15
[Association of -63A/C polymorphism of glutathione S-transferase M3 gene with essential hypertension in Chinese population].
2

About Manlong Qi

Manlong Qi is a scholar working on Cancer Research, Parasitology and Clinical Biochemistry, having authored 15 papers that have together received 514 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (4 papers), MicroRNA in disease regulation (3 papers) and Genomic variations and chromosomal abnormalities (3 papers). The work is most often cited by research in Cancer Research (321 citations), Molecular Biology (379 citations) and Immunology (69 citations). Manlong Qi has collaborated with scholars based in China and United States. Frequent co-authors include Xiang Fei, Kefeng Wang, Yueping Wang, Xia Wang, Jun Yang, Tingting Li, Yongsheng Song, Bin Wu, Kun Ling and Xia Wang. Their work appears in journals such as FEBS Letters, International Journal of Molecular Sciences and Gene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026